Gubra soars 23% on on AbbVie obesity drug licensing deal

Finance
7



[
Gubra soars 23% on on AbbVie obesity drug licensing deal
[og_img]
https://www.investing.com/news/stock-market-news/gubra-soars-23-on-on-abbvie-obesity-drug-licensing-deal-3901718


Investing.com

Montather Rassoul
Montather Rassoulhttps://thefifthskill.com/

Latest articles

spot_imgspot_img
Previous article
Shares in Mixue—a Chinese ice cream chain with more stores than McDonald’s—jump over 40% after Hong Kong’s largest IPO so far this year
Next article
Government spending could be separated from GDP reports—doing so could distort a fundamental measure of the U.S. economy’s health

Related articles

spot_imgspot_img